PubRank

Diseases (Basel, Switzerland) (Diseases)

Journal PubWeight™ 4.60‹?›

Top papers

Rank Title Year PubWeight™‹?›
1 Ginseng Metabolites on Cancer Chemoprevention: An Angiogenesis Link? 2015 0.85
2 The Developmental Trajectory of Self-Injurious Behaviours in Individuals with Prader Willi Syndrome, Autism Spectrum Disorder and Intellectual Disability. 2016 0.77
3 The Role of Glucosinolate Hydrolysis Products from Brassica Vegetable Consumption in Inducing Antioxidant Activity and Reducing Cancer Incidence. 2016 0.76
4 Nonsense Suppression as an Approach to Treat Lysosomal Storage Diseases. 2016 0.75
5 Keratoacanthoma Pathobiology in Mouse Models. 2014 0.75
6 Zebrafish Models of Prader-Willi Syndrome: Fast Track to Pharmacotherapeutics. 2016 0.75
7 Protein Kinase C Epsilon Contributes to NADPH Oxidase Activation in a Pre-Eclampsia Lymphoblast Cell Model. 2013 0.75
8 MeCP2-Related Diseases and Animal Models. 2014 0.75
9 Acute Demyelinating Encephalomyelitis Post-COVID-19 Vaccination: A Case Report and Literature Review. 2022 0.75
10 The Contribution of New Areas to the Total Hirsutism Scores in Basrah Hirsute Women. 2017 0.75
11 Blood and Salivary Inflammatory Biomarkers Profile in Patients with Chronic Kidney Disease and Periodontal Disease: A Systematic Review. 2022 0.75
12 The Vascular Factor Plays the Main Role in the Cause of Pain in Men with Chronic Prostatitis and Chronic Pelvic Pain Syndrome: The Results of Clinical Trial on Thermobalancing Therapy. 2017 0.75
13 An Overview of Dietary Interventions and Strategies to Optimize the Management of Non-Alcoholic Fatty Liver Disease. 2017 0.75
14 Relationship between Bone Health Biomarkers and Cardiovascular Risk in a General Adult Population. 2017 0.75
15 D-Amino Acids as a Biomarker in Schizophrenia. 2022 0.75
16 Relation between the Disability of the Arm, Shoulder and Hand Score and Muscle Strength in Post-Cardiac Surgery Patients. 2017 0.75
17 Helicobacter pylori-Mediated Protection against Extra-Gastric Immune and Inflammatory Disorders: The Evidence and Controversies. 2015 0.75
18 Competitive Promoter-Associated Matrix Attachment Region Binding of the Arid3a and Cux1 Transcription Factors. 2017 0.75
19 Emerging Biomarkers for Diagnosis, Prevention and Treatment of Brain Metastases-From Biology to Clinical Utility. 2022 0.75
20 Growth Hormone Therapy in Adults with Prader-Willi Syndrome. 2015 0.75
21 Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib. 2015 0.75
22 Medication Trials for Hyperphagia and Food-Related Behaviors in Prader-Willi Syndrome. 2015 0.75
23 Celiac Disease: Diagnostic Standards and Dilemmas. 2015 0.75
24 The Perceived Social Burden in Celiac Disease. 2015 0.75
25 Auxo-Endocrinological Approach to Celiac Children. 2015 0.75
26 Diagnosis of Helicobacter pylori: Changes towards the Future. 2015 0.75
27 The Gluten-Free Diet in the 3rd Millennium: Rules, Risks and Opportunities. 2015 0.75
28 Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent. 2015 0.75
29 Endovascular Repair of Aortic Dissection in Marfan Syndrome: Current Status and Future Perspectives. 2015 0.75
30 Metabolomic Approaches in Cancer Epidemiology. 2015 0.75
31 Kid-Short Marfan Score (Kid-SMS) Is a Useful Diagnostic Tool for Stratifying the Pre-Test Probability of Marfan Syndrome in Childhood. 2015 0.75
32 The Effects of Vitamin D Supplementation on Pulmonary Function of Chronic Obstructive Pulmonary Disease Patients, before and after Clinical Trial. 2015 0.75
33 Prognostication in Pulmonary Arterial Hypertension with Submaximal Exercise Testing. 2015 0.75
34 Pathology is Always Around Us: Apophenia in Pathology, a Remarkable Unreported Phenomenon. 2019 0.75
35 A Surgical Perspective on Targeted Therapy of Hepatocellular Carcinoma. 2015 0.75
36 Synergistic Anticancer Activities of Natural Substances in Human Hepatocellular Carcinoma. 2015 0.75
37 The Role of Environmental Factors in the Development of Celiac Disease: What Is New? 2015 0.75
38 Targeting FGF19/FGFR4 Pathway: A Novel Therapeutic Strategy for Hepatocellular Carcinoma. 2015 0.75
39 Clinical Development of c-MET Inhibition in Hepatocellular Carcinoma. 2015 0.75
40 New Tools for Molecular Therapy of Hepatocellular Carcinoma. 2015 0.75
41 An Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases. 2015 0.75
42 Systemic Chemotherapy for Advanced Hepatocellular Carcinoma: Past, Present, and Future. 2015 0.75
43 Puzzle Pieces: Neural Structure and Function in Prader-Willi Syndrome. 2015 0.75
44 Hepatocellular Carcinoma: Past and Future of Molecular Target Therapy. 2015 0.75
45 Prader-Willi Syndrome and Schaaf-Yang Syndrome: Neurodevelopmental Diseases Intersecting at the MAGEL2 Gene. 2016 0.75
46 Phytoconstituents with Radical Scavenging and Cytotoxic Activities from Diospyros shimbaensis. 2016 0.75
47 Obesity and Prader-Willi Syndrome Affect Heart Rate Recovery from Dynamic Resistance Exercise in Youth. 2016 0.75
48 Pituitary-Adrenal Axis in Prader Willi Syndrome. 2016 0.75
49 HBV Core Protein Enhances Cytokine Production. 2015 0.75
50 Personalised External Aortic Root Support (PEARS) Compared with Alternatives for People with Life-Threatening Genetically Determined Aneurysms of the Aortic Root. 2015 0.75
Next 50